Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2024/859 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the pharmacologically active substance ‘sodium salicylate’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Sodium salicylate NOT APPLICABLE Bovine, Porcine No MRL required NOT APPLICABLE For oral use. Not for use in animals from which milk is produced for human consumption. NO ENTRY All food producing species except fin fish No MRL required For topical use only. Salicylic acid Turkey 400 μg/kg 2 500 μg/kg 200 μg/kg 150 μg/kg Muscle Skin and fat in natural proportions Liver Kidney Not for use in animals producing eggs for human consumption. Anti-inflammatory agents / Non-steroidal anti-inflammatory agents’. Poultry other than turkey 250 μg/kg 250 μg/kg 500 μg/kg 1 000 μg/kg Muscle Skin and fat in natural proportions Liver Kidney
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.